Author information:
(1)Neurology Clinic, University of Heidelberg, Heidelberg, Germany. Clinical 
Cooperation Unit (CCU) Neurooncology, German Cancer Consortium (DKTK), German 
Cancer Research Center (DKFZ), Heidelberg, Germany. 
wolfgang.wick@med.uni-heidelberg.de.
(2)European Organisation for Research and Treatment of Cancer (EORTC), Lausanne, 
Switzerland.
(3)SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland. Neuroscience 
Research Center, University Hospital Lausanne (CHUV), Lausanne, Switzerland.
(4)Neurology Clinic, University of Heidelberg, Heidelberg, Germany. CCU Brain 
Tumor Immunology, DKFZ, Heidelberg, Germany.
(5)Department of Neurology/Neuro-Oncology, Erasmus MC - Cancer Institute, 
Rotterdam, the Netherlands.
(6)Neuro-oncology Unit, MC Haaglanden, The Hague, the Netherlands.
(7)Department of Medical Oncology, Ospedale Bellaria, Bologna, Italy.
(8)Neuroscience Research Center, University Hospital Lausanne (CHUV), Lausanne, 
Switzerland. Department of Neurosurgery, CHUV, Lausanne, Switzerland.
(9)Neurology Clinic, University of Heidelberg, Heidelberg, Germany.
(10)Pfizer, Berlin, Germany.
(11)Department of Neurology, University Hospital and University of Zurich, 
Switzerland.
(12)Department of Neurosurgery, CHUV, Lausanne, Switzerland.
(13)1-Institut de Cancérologie de l'OUEST, Saint Herblain-Nantes Cedex, France.
(14)AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Service de Neurologie 
2-Mazarin, UMR8257 MD4 Cognac G, CNRS, Service de Santé des Armées, Université 
Paris Descartes, Paris, France.
(15)General Hospital AKH, Medical University Vienna, Austria.
(16)Institut Catala d'Oncologia (ICO), Hospital Germans Trias Pujol, Badalona, 
Barcelona, Spain.
(17)Department of Neurosurgery, Medical Center, University of Freiburg, Germany.
(18)University Hospitals Bristol NHS Foundation Trust - Bristol Haematology and 
Oncology Centre, Bristol, United Kingdom.
(19)Department of Oncology, CHUV, Lausanne, Switzerland.
(20)Institute of Pathology, CHUV, Lausanne, Switzerland.
(21)Department of Radio-oncology, Oncology Institute of Southern Switzerland, 
Bellinzona, Switzerland.